Onset and treatment of infantile leukaemia
17 Jun 2018
Onset and treatment of infantile leukaemia
Novel CD22 CAR-T therapy for paediatric leukaemia
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia
EHA Topics in focus : Immunotherapy
Novel ADC for relapsed/refractory lymphoma
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
Updated results from a phase I trial of CAR-T cell therapy for r/rMM
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma
Updates from Myeloma XI trial
Ribosomal lesions promote oncogenic mutagenesis
Updated data from the FORTE trial of carfilzomib plus lenalidomide or cyclophosphamide for myeloma
Interim results of RELEVANCE trial in follicular lymphoma